CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-9.4%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.79B
AUM Growth
+$2.79B
(-9.3%)
Cap. Flow
+$60.3M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
57.47%
Holding
43
New
4
Increased
14
Reduced
10
Closed
3
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$89.8M |
| 2 |
Medtronic
MDT
|
$70.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
$48.5M |
| 4 |
Globus Medical
GMED
|
$36M |
| 5 |
Tenet Healthcare
THC
|
$29.7M |
Top Sells
| 1 |
Sanofi
SNY
|
$67.1M |
| 2 |
Quanterix
QTRX
|
$58.4M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$51.2M |
| 4 |
GSK
GSK
|
$45.3M |
| 5 |
Exelixis
EXEL
|
$27.3M |
Sector Composition
| 1 | Healthcare | 96.13% |
| 2 | Consumer Staples | 2.51% |
| 3 | Consumer Discretionary | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.3B
| $26.5M | 0.87% |
+300,000
| New | +$26.5M |
|
27
OraSure Technologies
OSUR
$230M
| $25.2M | 0.83% |
4,250,000
| – | – |
|
28
QuidelOrtho
QDEL
$1.87B
| $23.7M | 0.78% |
+325,000
| New | +$23.7M |
|
29
Collegium Pharmaceutical
COLL
$1.25B
| $23.5M | 0.77% |
1,050,000
| – | – |
|
30
Peloton Interactive
PTON
$3.1B
| $22.7M | 0.75% |
4,500,000
+1,500,000
| +50% | +$7.58M |
|
31
Qiagen
QGEN
$10.1B
| $16.2M | 0.53% |
+377,222
| New | +$16.2M |
|
|
BKDT
32
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| $15.1M | 0.5% |
250,000
| – | – |
|
33
CureVac
CVAC
$1.21B
| $12M | 0.39% |
1,750,000
+287,500
| +20% | +$1.96M |
|
34
Puma Biotechnology
PBYI
$258M
| $11.1M | 0.37% |
4,235,000
| – | – |
|
35
Inogen
INGN
$213M
| $10.4M | 0.34% |
2,000,000
+850,000
| +74% | +$4.44M |
|
|
BCYC
36
Bicycle Therapeutics
BCYC
$492M
| $8.04M | 0.26% |
+400,000
| New | +$8.04M |
|
|
37
Exelixis
EXEL
$9.95B
| $6.56M | 0.22% |
300,000
-1,250,000
| -81% | -$27.3M |
|
38
Solid Biosciences
SLDB
$448M
| $3.57M | 0.12% |
1,418,439
| – | – |
|
|
CANO
39
DELISTED
Cano Health, Inc.
CANO
| $1.01M | 0.03% |
40,000
| – | – |
|
40
Centene
CNC
$14.8B
| – | – |
-400,000
| Closed | -$27M |
|
41
Dynavax Technologies
DVAX
$1.19B
| – | – |
-300,000
| Closed | -$3.88M |
|
42
Glaukos
GKOS
$5.42B
| – | – |
-160,000
| Closed | -$11.4M |
|
43
Pfizer
PFE
$141B
| – | – |
0
| – | – |
|